These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vaccine designers take first shots at COVID-19. Cohen J Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928 [No Abstract] [Full Text] [Related]
25. Preparing for the vaccine. Nat Biotechnol; 2020 Nov; 38(11):1219. PubMed ID: 33110209 [TBL] [Abstract][Full Text] [Related]
26. Protect against market exclusivity in the fight against COVID-19. 't Hoen E Nat Med; 2020 Jun; 26(6):813. PubMed ID: 32382151 [No Abstract] [Full Text] [Related]
27. [COVID-19: Impact of a pandemic]. Cuestas ML; Minassian ML Rev Argent Microbiol; 2020; 52(3):167-168. PubMed ID: 33032744 [No Abstract] [Full Text] [Related]
28. This newly recognized coronavirus makes one wonder why we were so unprepared. Calisher CH Croat Med J; 2020 Apr; 61(2):201-204. PubMed ID: 32378391 [No Abstract] [Full Text] [Related]
29. Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon. Dawson L; Earl J; Livezey J J Infect Dis; 2020 Jul; 222(3):514-516. PubMed ID: 32496536 [No Abstract] [Full Text] [Related]
30. SARS-CoV-2 Vaccines: Status Report. Amanat F; Krammer F Immunity; 2020 Apr; 52(4):583-589. PubMed ID: 32259480 [TBL] [Abstract][Full Text] [Related]
31. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
32. Audio Interview: Covid-19 in Europe and New Information on Vaccines. Rubin EJ; Baden LR; Haug CJ; Morrissey S N Engl J Med; 2020 Nov; 383(21):e134. PubMed ID: 33207102 [No Abstract] [Full Text] [Related]
34. A vaccine is not too far for COVID-19. Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830 [No Abstract] [Full Text] [Related]
35. COVID-19 vaccine trials: Duty of care and standard of prevention considerations. Singh JA Vaccine; 2020 Nov; 38(48):7578-7580. PubMed ID: 33069443 [No Abstract] [Full Text] [Related]
36. Acceptance of a COVID-19 vaccine: A multifactorial consideration. GarcĂa LY; Cerda AA Vaccine; 2020 Nov; 38(48):7587. PubMed ID: 33121656 [No Abstract] [Full Text] [Related]
37. Coronavirus Disease 2019: Is Everything Lawful to Create an Effective Vaccine? Cioffi A J Infect Dis; 2020 Jun; 222(1):169. PubMed ID: 32348489 [No Abstract] [Full Text] [Related]